Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma.
about
Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Salvage pembrolizumab added to ...... anaplastic thyroid carcinoma.
@en
Salvage pembrolizumab added to ...... anaplastic thyroid carcinoma.
@nl
type
label
Salvage pembrolizumab added to ...... anaplastic thyroid carcinoma.
@en
Salvage pembrolizumab added to ...... anaplastic thyroid carcinoma.
@nl
prefLabel
Salvage pembrolizumab added to ...... anaplastic thyroid carcinoma.
@en
Salvage pembrolizumab added to ...... anaplastic thyroid carcinoma.
@nl
P2093
P2860
P50
P1476
Salvage pembrolizumab added to ...... anaplastic thyroid carcinoma.
@en
P2093
Erich M Sturgis
G Brandon Gunn
Heath D Skinner
Horiana Grosu
Maria E Cabanillas
Maria Gule-Monroe
Naifa L Busaidy
Neil Gross
Priyanka C Iyer
Ramona Dadu
P2860
P2888
P356
10.1186/S40425-018-0378-Y
P577
2018-07-11T00:00:00Z
P6179
1105485481